Intuitive Surgical, Inc. $ISRG Shares Bought by Trifecta Capital Advisors LLC

Trifecta Capital Advisors LLC grew its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.4% in the second quarter, Holdings Channel reports. The institutional investor owned 13,368 shares of the medical equipment provider’s stock after acquiring an additional 802 shares during the quarter. Intuitive Surgical accounts for 1.2% of Trifecta Capital Advisors LLC’s holdings, making the stock its 28th largest holding. Trifecta Capital Advisors LLC’s holdings in Intuitive Surgical were worth $7,264,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also added to or reduced their stakes in ISRG. Chilton Capital Management LLC boosted its holdings in Intuitive Surgical by 614.3% in the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 43 shares during the last quarter. Elite Financial Inc. purchased a new position in shares of Intuitive Surgical during the first quarter worth $26,000. LFA Lugano Financial Advisors SA acquired a new position in Intuitive Surgical during the 1st quarter worth about $30,000. TD Capital Management LLC lifted its stake in Intuitive Surgical by 300.0% during the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock worth $30,000 after acquiring an additional 45 shares in the last quarter. Finally, 1248 Management LLC acquired a new position in shares of Intuitive Surgical in the first quarter valued at approximately $30,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Price Performance

ISRG opened at $448.09 on Thursday. The business has a 50-day moving average of $460.50 and a two-hundred day moving average of $499.05. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $616.00. The stock has a market capitalization of $160.63 billion, a price-to-earnings ratio of 62.50, a price-to-earnings-growth ratio of 4.64 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, topping analysts’ consensus estimates of $1.93 by $0.26. The company had revenue of $2.44 billion for the quarter, compared to the consensus estimate of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. Intuitive Surgical’s revenue was up 21.4% on a year-over-year basis. During the same quarter last year, the firm posted $1.78 earnings per share. Equities research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Activity at Intuitive Surgical

In related news, Director Amy L. Ladd sold 336 shares of the company’s stock in a transaction on Wednesday, September 3rd. The shares were sold at an average price of $470.11, for a total transaction of $157,956.96. Following the completion of the sale, the director directly owned 1,074 shares of the company’s stock, valued at approximately $504,898.14. This represents a 23.83% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Gary S. Guthart sold 29,360 shares of the business’s stock in a transaction dated Friday, August 29th. The stock was sold at an average price of $472.49, for a total value of $13,872,306.40. Following the transaction, the insider owned 19,827 shares in the company, valued at approximately $9,368,059.23. This represents a 59.69% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 45,224 shares of company stock worth $21,716,492. Company insiders own 0.70% of the company’s stock.

Analyst Ratings Changes

ISRG has been the topic of several recent analyst reports. Truist Financial increased their target price on Intuitive Surgical from $590.00 to $600.00 and gave the company a “buy” rating in a report on Wednesday, July 23rd. Wall Street Zen upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Saturday, October 4th. The Goldman Sachs Group decreased their price objective on shares of Intuitive Surgical from $621.00 to $567.00 and set a “buy” rating on the stock in a report on Wednesday, October 1st. UBS Group lifted their price target on shares of Intuitive Surgical from $547.00 to $585.00 and gave the company a “neutral” rating in a research report on Wednesday, July 23rd. Finally, Erste Group Bank reiterated a “hold” rating on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Fourteen research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus target price of $589.43.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.